Skip to main content

CDT Equity Inc.

CDTTW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001896212

In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $81.8K in total; no superinvestor holds it.

Other share classesCDT

Q3 2024 vs. Q2 2024

How the institutions holding CDT Equity Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CDTTW: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders25226+3
Shares7.22M329.0K7.12M+222.8K (+3.2%)
Value$155.9K$9.41K$110.7K−$35.8K (−24.4%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held CDT Equity Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CDTTW in Q3 2024
InstitutionSharesValue% of portfolio
Atw Spac Management LLC250,000$3.99K0.00%
Mizuho Securities USA LLC100,000$1.00K0.00%
Heights Capital Management, Inc78,958$9320.00%
Susquehanna International Group, LLP24,495$2890.00%
UBS Group AG516$60.00%

Sold out (2)

Institutions that held CDT Equity Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CDTTW in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Shaolin Capital Management LLC125,711$1.95K
Kim, LLC100,000$1.55K

Not filed for Q3 2024 yet (2)

Institutions that held CDT Equity Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CDTTW in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Arena Investors LP250,000$8.19K
CVI Holdings, LLC78,958$1.22K